On Thursday morning, the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) held a legislative markup hearing to debate amendments to S. 2333, the Pandemic and All-Hazards Preparedness and Response Act (PAHPARA), the reauthorization bill to extend the Pandemic and All-Hazards Preparedness Act (PAHPA). If enacted as currently drafted, PAHPARA would direct federal agencies to study alternative models for funding biomedical research, including prize systems that have been routinely rejected as a viable model by pro-innovation advocates.
Recent Posts
- Other Barks & Bites for Friday, May 9: USPTO Responds to GAO Report; Stewart Welcomes National Inventors Hall of Fame Inductees; CAFC Defines ‘Ground’ for IPR Estoppel Statute
- PTAB Designates as Informative Stewart Decision on Discretion to Institute in Context of Parallel District Court Litigation
- Judge Hughes Again Calls Out CAFC’s Overly Rigid Article III Analysis for Pharmaceutical Cases
- Coke Stewart’s Recent Show Cause Order Offers Hope for Addressing Serial Patent Challenges
- The USPTO Should Reintroduce the AFCP Program—Now